Development of baclofen tolerance in a rat model of chronic spasticity and rigidity

Neuroscience Letters

Volumn 403, Issue 1-2, 2006, Pages 195-200

  Hefferan, Michael P ^a   Fuchigami, Tatsuya ^a,b   Marsala, Martin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Baclofen; GABAB receptor; Rat; Spasticity; Spinal cord ischemia; Tolerance

Indexed keywords

BACLOFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOLUS INJECTION; CATHETER; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERANCE; HINDLIMB; MALE; MUSCLE RIGIDITY; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; RAT; SPASTICITY; SPINAL CORD ISCHEMIA; SPINE INJURY;

ANIMALS; BACLOFEN; CHRONIC DISEASE; DRUG TOLERANCE; INJECTIONS, SPINAL; ISCHEMIA; MALE; MUSCLE RIGIDITY; MUSCLE SPASTICITY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; SPINAL CORD;

EID: 33745488476     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.04.048     Document Type: Article

References (41)

1. Advokat C., and Gulati A. Spinal transection reduces both spinal antinociception and CNS concentration of systemically administered morphine in rats. Brain Res. 555 (1991) 251-258
2. Akman M.N., Loubser P.G., Donovan W.H., O'Neill M.E., and Rossi C.D. Intrathecal baclofen: does tolerance occur?. Paraplegia 31 (1993) 516-520
3. Beard S., Hunn A., and Wight J. Treatments for spasticity and pain in multiple sclerosis: a systematic review. Health Technol. Assess. 7 (2003) 1-124
4. Bertman L.J., and Advokat C. Comparison of the antinociceptive and antispastic action of (-)-baclofen after systemic and intrathecal administration in intact, acute and chronic spinal rats. Brain Res. 684 (1995) 8-18
5. Curtis D.R., and Malik R. The differential effects of baclofen on segmental and descending excitation of spinal interneurones in the cat. Exp. Brain Res. 58 (1985) 333-337
6. Dabney K.W., Lipton G.E., and Miller F. Cerebral palsy. Curr. Opin. Pediatr. 9 (1997) 81-88
7. Dario A., Scamoni C., Picano M., Casagrande F., and Tomei G. Pharmacological complications of the chronic baclofen infusion in the severe spinal spasticity. Personal experience and review of the literature. J. Neurosurg. Sci. 48 (2004) 177-181
8. Dietz V. Gait disorder in spasticity and Parkinson's disease. Adv. Neurol. 87 (2001) 143-154
9. Enna S.J., Harstad E.B., and McCarson K.E. Regulation of neurokinin-1 receptor expression by GABA(B) receptor agonists. Life Sci. 62 (1998) 1525-1530
10. Ferguson S.S. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol. Rev. 53 (2001) 1-24
11. Hao J.X., Xu X.J., Yu Y.X., Seiger A., and Wiesenfeld-Hallin Z. Baclofen reverses the hypersensitivity of dorsal horn wide dynamic range neurons to mechanical stimulation after transient spinal cord ischemia: implications for a tonic GABAergic inhibitory control of myelinated fiber input. J. Neurophysiol. 68 (1992) 392-396
12. Harrison L.M., Kastin A.J., and Zadina J.E. Opiate tolerance and dependence: receptors, G-proteins, and antiopiates. Peptides 19 (1998) 1603-1630
13. Hefferan M.P., O'Rielly D.D., and Loomis C.W. Inhibition of spinal prostaglandin synthesis early after L5/L6 nerve ligation prevents the development of prostaglandin-dependent and prostaglandin-independent allodynia in the rat. Anesthesiology 99 (2003) 1180-1188
14. Homma S., Suzuki T., Murayama S., and Otsuka M. Amino acid and substance P contents in spinal cord of cats with experimental hind-limb rigidity produced by occlusion of spinal cord blood supply. J. Neurochem. 32 (1979) 691-698
15. Ito T., Furukawa K., Karasawa T., Kadokawa T., and Shimizu M. Effects of chlorpromazine, imipramine and baclofen on the spinal polysynaptic reflex in acute, chronic and 6-hydroxydopamine-treated spinal rats. Jpn. J. Pharmacol. 32 (1982) 1125-1133
16. Kakulas B.A. A review of the neuropathology of human spinal cord injury with emphasis on special features. J. Spinal Cord. Med. 22 (1999) 119-124
17. B receptors in the rat substantia gelatinosa. J. Neurosurg. 79 (1993) 544-549
18. Lance J.W., Burke D., and Gillies J.D. An electromyographic analysis of spasticity. Trans Am. Neurol. Assoc. 95 (1970) 272-274
19. Lazorthes Y., Sallerin-Caute B., Verdie J.C., Bastide R., and Carillo J.P. Chronic intrathecal baclofen administration for control of severe spasticity. J. Neurosurg. 72 (1990) 393-402
20. Lazorthes Y., Sol J.C., Sallerin B., and Verdie J.C. The surgical management of spasticity. Eur. J. Neurol. 9 Suppl. 1 (2002) 35-41 (dicussion 53-61)
21. Lehmann A., Hansson-Branden L., and Karrberg L. Effects of repeated administration of baclofen on transient lower esophageal sphincter relaxation in the dog. Eur. J. Pharmacol. 403 (2000) 163-167
22. B receptor binding sites and subunit expression in the brain. Neurochem. Res. 28 (2003) 387-393
23. Li Y., Li X., Harvey P.J., and Bennett D.J. Effects of baclofen on spinal reflexes and persistent inward currents in motoneurons of chronic spinal rats with spasticity. J. Neurophysiol. 92 (2004) 2694-2703
24. B receptor in rat spinal cord detected by autoradiography. Eur. J. Pharmacol. 250 (1993) 153-156
25. Marsala M., Hefferan M.P., Kakinohana O., Nakamura S., Marsala J., and Tomori Z. Measurement of peripheral muscle resistance in rats with chronic ischemia-induced paraplegia or morphine-induced rigidity using a semi-automated computer-controlled muscle resistance meter. J. Neurotrauma 22 (2005) 1348-1361
26. Maurice V., Allan H.R., and Raymond D.A. Adams & Victor's Principles of Neurology. seventh ed. (2001), McGraw-Hill Companies
27. Milla P.J., and Jackson A.D. A controlled trial of baclofen in children with cerebral palsy. J. Int. Med. Res. 5 (1977) 398-404
28. Montane E., Vallano A., and Laporte J.R. Oral antispastic drugs in nonprogressive neurologic diseases: a systematic review. Neurology 63 (2004) 1357-1363
29. Nielsen J.F., Hansen H.J., Sunde N., and Christensen J.J. Evidence of tolerance to baclofen in treatment of severe spasticity with intrathecal baclofen. Clin. Neurol. Neurosurg. 104 (2002) 142-145
30. Patel S., Naeem S., Kesingland A., Froestl W., Capogna M., Urban L., and Fox A. The effects of GABA(B) agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the rat. Pain 90 (2001) 217-226
31. Plassat R., Perrouin Verbe B., Menei P., Menegalli D., Mathe J.F., and Richard I. Treatment of spasticity with intrathecal Baclofen administration: long-term follow-up, review of 40 patients. Spinal Cord 42 (2004) 686-693
32. B receptor binding sites in rat frontal cortex. Br. J. Pharmacol. 110 (1993) 724-735
33. Quevedo J., Eguibar J.R., Jimenez I., and Rudomin P. Differential action of (-)-baclofen on the primary afferent depolarization produced by segmental and descending inputs. Exp. Brain Res. 91 (1992) 29-45
34. Rainov N.G., Heidecke V., and Burkert W. Long-term intrathecal infusion of drug combinations for chronic back and leg pain. J. Pain Symptom Manage 22 (2001) 862-871
35. Sands S.A., McCarson K.E., and Enna S.J. Differential regulation of GABA B receptor subunit expression and function. J. Pharmacol. Exp. Ther. 305 (2003) 191-196
36. Sanger T.D., Delgado M.R., Gaebler-Spira D., Hallett M., and Mink J.W. Classification and definition of disorders causing hypertonia in childhood. Pediatrics 111 (2003) e89-e97
37. Taira Y., and Marsala M. Effect of proximal arterial perfusion pressure on function, spinal cord blood flow, and histopathologic changes after increasing intervals of aortic occlusion in the rat. Stroke 27 (1996) 1850-1858
38. Verrotti A., Greco R., Spalice A., Chiarelli F., and Iannetti P. Pharmacotherapy of spasticity in children with cerebral palsy. Pediatr. Neurol. 34 (2006) 1-6
39. Wang D.C., Bose P., Parmer R., and Thompson F.J. Chronic intrathecal baclofen treatment and withdrawal: I. Changes in ankle torque and hind limb posture in normal rats. J. Neurotrauma 19 (2002) 875-886
40. Yaksh T., and Rudy T. Chronic catheterization of the spinal subarachnoid space. Physiol. Behavior. 17 (1976) 1031-1036
41. Yaksh T.L., Kohl R.L., and Rudy T.A. Induction of tolerance and withdrawal in rats receiving morphine in the spinal subarachnoid space. Eur. J. Pharmacol. 42 (1977) 275-284